BL Harbert will renovate existing and construct new facilities at Tinker AFB in Oklahoma under a contract awarded by USACE.
In a Phase III trial, sacituzumab tirumotecan outperformed chemo in previously treated EGFR-mutant NSCLC patients, results presented at the ESMO Congress show.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback